tiprankstipranks
Biofil Chemicals & Pharmaceuticals Ltd. (IN:BIOFILCHEM)
:BIOFILCHEM
India Market
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Ltd.
RESEARCH TOOLSreports

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) Ratios

0 Followers

Biofil Chemicals & Pharmaceuticals Ltd. Ratios

IN:BIOFILCHEM's free cash flow for Q2 2026 was ₹0.03. For the 2026 fiscal year, IN:BIOFILCHEM's free cash flow was decreased by ₹ and operating cash flow was ₹<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.44 1.34 1.35 1.63 6.23
Quick Ratio
 1.33 1.23 1.26 1.54 5.37
Cash Ratio
 <0.01 <0.01 0.08 <0.01 0.10
Solvency Ratio
 0.09 0.03 0.04 0.07 0.59
Operating Cash Flow Ratio
 -0.11 -0.06 0.08 >-0.01 -0.15
Short-Term Operating Cash Flow Coverage
 -178.26 -4.08 5.45 -0.21 -0.47
Net Current Asset Value
₹ 143.59M₹ 103.75M₹ 95.28M₹ 82.50M₹ 74.18M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.02 0.02
Debt-to-Equity Ratio
 <0.01 0.03 0.02 0.03 0.03
Debt-to-Capital Ratio
 <0.01 0.02 0.02 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.60 2.71 2.59 1.82 1.11
Debt Service Coverage Ratio
 80.05 1.92 2.39 1.83 2.31
Interest Coverage Ratio
 2.40 12.68 10.05 17.38 22.29
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.02 0.31 0.30 0.35 0.31
Net Debt to EBITDA
 -0.06 0.29 -1.41 0.38 0.22
Profitability Margins
Gross Profit Margin
5.26%6.26%6.31%8.53%12.80%
EBIT Margin
10.88%2.31%2.26%2.78%4.72%
EBITDA Margin
11.84%3.45%3.26%4.21%6.63%
Operating Profit Margin
0.14%1.40%1.04%2.46%4.04%
Pretax Profit Margin
11.09%2.20%2.16%2.64%4.53%
Net Profit Margin
9.50%1.67%1.77%1.87%3.12%
Continuous Operations Profit Margin
9.50%1.67%1.77%1.87%3.12%
Net Income Per EBT
85.74%75.78%81.96%70.67%68.81%
EBT Per EBIT
7738.52%157.32%207.46%107.37%112.14%
Return on Assets (ROA)
5.01%1.09%1.51%1.78%3.73%
Return on Equity (ROE)
14.36%2.97%3.90%3.24%4.15%
Return on Capital Employed (ROCE)
0.19%2.45%2.25%4.18%5.25%
Return on Invested Capital (ROIC)
0.17%1.81%1.80%2.87%3.52%
Return on Tangible Assets
5.01%1.09%1.51%1.78%3.73%
Earnings Yield
4.90%0.80%0.65%0.83%0.74%
Efficiency Ratios
Receivables Turnover
 0.72 0.87 1.21 1.46 3.12
Payables Turnover
 0.83 1.01 1.36 2.17 32.73
Inventory Turnover
 7.94 9.37 14.71 22.64 15.09
Fixed Asset Turnover
 4.20 4.00 4.64 3.34 2.38
Asset Turnover
 0.53 0.66 0.85 0.96 1.19
Working Capital Turnover Ratio
 3.97 3.24 4.33 3.65 3.08
Cash Conversion Cycle
 115.86 96.40 57.79 97.21 130.11
Days of Sales Outstanding
 509.96 418.68 301.12 249.16 117.07
Days of Inventory Outstanding
 45.98 38.95 24.81 16.12 24.19
Days of Payables Outstanding
 440.08 361.24 268.15 168.07 11.15
Operating Cycle
 555.94 457.64 325.94 265.28 141.26
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.19 -1.17 1.49 -0.07 -0.14
Free Cash Flow Per Share
 -2.23 -1.23 1.47 -0.08 -0.18
CapEx Per Share
 0.04 0.06 0.01 <0.01 0.04
Free Cash Flow to Operating Cash Flow
 1.02 1.05 0.99 1.09 1.32
Dividend Paid and CapEx Coverage Ratio
 -50.57 -19.22 104.53 -10.55 -3.15
Capital Expenditure Coverage Ratio
 -50.57 -19.22 104.53 -10.55 -3.15
Operating Cash Flow Coverage Ratio
 -178.26 -4.08 5.45 -0.21 -0.47
Operating Cash Flow to Sales Ratio
 -0.12 -0.06 0.06 >-0.01 >-0.01
Free Cash Flow Yield
-6.42%-2.90%2.16%-0.18%-0.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 20.43 125.09 154.77 120.22 134.33
Price-to-Sales (P/S) Ratio
 1.94 2.09 2.74 2.24 4.19
Price-to-Book (P/B) Ratio
 2.66 3.72 6.03 3.89 5.57
Price-to-Free Cash Flow (P/FCF) Ratio
 -15.58 -34.48 46.30 -550.44 -323.74
Price-to-Operating Cash Flow Ratio
 -15.89 -36.27 45.86 -602.63 -426.64
Price-to-Earnings Growth (PEG) Ratio
 -7.15 -5.50 5.26 -5.74 -3.09
Price-to-Fair Value
 2.66 3.72 6.03 3.89 5.57
Enterprise Value Multiple
 16.33 60.83 82.62 53.66 63.48
Enterprise Value
 564.35M 701.13M 1.08B 678.58M 941.38M
EV to EBITDA
 16.33 60.83 82.62 53.66 63.48
EV to Sales
 1.93 2.10 2.70 2.26 4.21
EV to Free Cash Flow
 -15.52 -34.65 45.52 -554.40 -324.84
EV to Operating Cash Flow
 -15.83 -36.45 45.09 -606.96 -428.10
Tangible Book Value Per Share
 13.09 11.41 11.29 10.63 10.35
Shareholders’ Equity Per Share
 13.09 11.41 11.29 10.63 10.35
Tax and Other Ratios
Effective Tax Rate
 0.14 0.24 0.18 0.29 0.31
Revenue Per Share
 17.93 20.29 24.84 18.46 13.75
Net Income Per Share
 1.70 0.34 0.44 0.34 0.43
Tax Burden
 0.86 0.76 0.82 0.71 0.69
Interest Burden
 1.02 0.95 0.96 0.95 0.96
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.02 0.01 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.68 -2.61 3.38 -0.14 -0.31
Currency in INR